These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34265605)

  • 1. Differential procoagulatory response of microvascular, arterial and venous endothelial cells upon inflammation in vitro.
    Brandtner AK; Lehner GF; Pircher A; Feistritzer C; Joannidis M
    Thromb Res; 2021 Sep; 205():70-80. PubMed ID: 34265605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
    Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
    Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
    Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.
    Lupu C; Westmuckett AD; Peer G; Ivanciu L; Zhu H; Taylor FB; Lupu F
    Am J Pathol; 2005 Oct; 167(4):1161-72. PubMed ID: 16192650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
    Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
    Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1β.
    Kamegashira A; Yanase Y; Takahagi S; Saito R; Uchida K; Kawaguchi T; Ishii K; Tanaka A; Ozawa K; Hide M
    J Dermatol; 2020 Nov; 47(11):1293-1300. PubMed ID: 32748974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
    Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
    Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice.
    Subramaniam S; Boukhlouf S; Fletcher C
    Blood Coagul Fibrinolysis; 2019 Oct; 30(7):324-330. PubMed ID: 31490208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tissue factor on monocytes by adhesion to endothelial cells.
    Lo SK; Cheung A; Zheng Q; Silverstein RL
    J Immunol; 1995 May; 154(9):4768-77. PubMed ID: 7536780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tissue factor pathway in disseminated intravascular coagulation.
    Østerud B; Bjørklid E
    Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.
    Drake TA; Cheng J; Chang A; Taylor FB
    Am J Pathol; 1993 May; 142(5):1458-70. PubMed ID: 7684196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
    Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
    J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.
    Mattsson E; Heying R; van de Gevel JS; Hartung T; Beekhuizen H
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):110-7. PubMed ID: 18031538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.
    Friedl J; Puhlmann M; Bartlett DL; Libutti SK; Turner EN; Gnant MF; Alexander HR
    Blood; 2002 Aug; 100(4):1334-9. PubMed ID: 12149215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.
    Stojkovic S; Kaun C; Basilio J; Rauscher S; Hell L; Krychtiuk KA; Bonstingl C; de Martin R; Gröger M; Ay C; Holnthoner W; Eppel W; Neumayer C; Huk I; Huber K; Demyanets S; Wojta J
    Sci Rep; 2016 May; 6():25171. PubMed ID: 27142573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.